PATENT CLAIM ANALYSIS

Application Number: 16064377
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "654000"]

Abstract:
Metabolism-resistant fenfluramine analogs are provided. The subject fenfluramine analogs find use in the treatment of a variety of diseases. For example, methods of treating epilepsy by administering a fenfluramine analog to a subject in need thereof are provided. Also provided are methods of suppressing appetite in a subject in need thereof. Pharmaceutical compositions for use in practicing the subject methods are also provided.

Claim (Index 14):
The method of  claim 10 , wherein the compound is of formula (IV): wherein X 8 -X 10  and each X is independently H, D or F, provided at least one X 8 -X 10  or X is F.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 94.0
- Lexical Diversity: 1.86486
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15055403', '11033079', '12691607', '13718632', '11825395']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7612419825001462
- 35 USC 102 Novelty (BERT): 0.5212656944369131
- Combined Prediction Score: 0.7372443536938229
- Mean Citation Score: 289.148744
- Max Citation Score: 297.5369
- Similarity Product: 218.2882921830177

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test